| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $170K | +750.0% | +213.6% |
| SG&A Expense | $6.2M | +71.4% | -88.3% |
| Operating Income | -$6.4M | -75.1% | +88.0% |
| Interest Expense | $5K | — | — |
| Pre-tax Income | -$6.4M | -105.7% | +88.2% |
| Net Income | -$6.4M | -105.7% | +88.2% |
| EPS (Basic) | -$0.28 | +6.7% | +97.8% |
| EPS (Diluted) | -$0.28 | +6.7% | +97.8% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $8.2M | +6.7% | -15.5% |
| Total Assets | $14.3M | -5.1% | -36.4% |
| Current Liabilities | $3.5M | -4.1% | -19.9% |
| Long-term Debt | $55K | +0.0% | -87.5% |
| Total Liabilities | $3.5M | -4.2% | -21.0% |
| Stockholders' Equity | $9.8M | -6.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$4.1M | — | — |
| Capital Expenditures | $5K | — | — |
| Investing Cash Flow | -$5K | — | — |
| Financing Cash Flow | $4.5M | — | — |
| Free Cash Flow | -$4.1M | — | — |
| -45.7% |